XML 32 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equity Method Accounting for Common Stock of Asterias, at fair value (Tables)
 9 Months Ended
Sep. 30, 2016
Equity Method Accounting for Common Stock of Asterias, at fair value [Abstract]  
Unaudited condensed financial statements information and operations
The unaudited condensed results of operations and unaudited condensed balance sheet information of Asterias are summarized below (in thousands):

 
 
Three months
ended
September 30,
2016
 
Nine months
ended
September 30,
2016
 
For the Period
May 13, 2016
 through
September 30,
2016 (2)
 
Condensed Statements of Operations (1):
 
 
 
 
 
 
 
 
 
 
Total revenue
 
$
2,076
 
 
$
5,202
 
 
$
2,848
 
 
Gross profit
 
 
2,017
 
 
 
5,084
 
 
 
2,783
 
 
Loss from operations
 
 
(7,425
) 
 
(25,591
)
 
 
(11,647
)
 
Net loss
 
$
(10,648
) 
$
(26,144
)
 
$
(11,991
)
 

 
 
September 30, 2016
 
December 31, 2015
 
Condensed Balance Sheet information (1):
 
 
 
 
 
 
 
Current assets
 
$
35,914
 
 
$
12,783
 
 
Noncurrent assets
 
 
34,389
 
 
 
27,445
 
 
 
 
$
70,303
 
 
$
40,228
 
 
 
 
 
 
 
 
 
 
 
 
Current liabilities
 
$
8,876
 
 
$
4,450
 
 
Noncurrent liabilities
 
 
18,701
 
 
 
4,605
 
 
Stockholders’ equity
 
 
42,726
 
 
 
31,173
 
 
 
 
$
70,303
 
 
$
40,228
 
 

(1) The condensed unaudited statement of operations information included in the table above reflects Asterias’ results of operations for the three and nine months ended September 30, 2016. Asterias unaudited results of operations for the period from January 1, 2016 through May 12, 2016, the date immediately preceding the Deconsolidation, are included in the unaudited consolidated results of operations of BioTime for the nine months ended September 30, 2016 shown in the table below. The condensed unaudited balance sheet information of Asterias included in the table above was included in BioTime’s consolidated balance sheet at December 31, 2015, after intercompany eliminations.
 
(2) The condensed unaudited statement of operations information for the period May 13, 2016 through September 30, 2016 is not included in the unaudited consolidated results of BioTime for the three and nine months ended September 30, 2016 due to the Deconsolidation of Asterias on May 13, 2016.
 

The following table summarizes Asterias’ unaudited results of operations that are included in BioTime’s unaudited consolidated results of operations, after intercompany eliminations, for the period from January 1, 2016 through May 12, 2016, the date immediately preceding the deconsolidation of Asterias, and for the three and nine months ended September 30, 2015 (unaudited) (in thousands).

 
 
For the Period
January 1, 2016
through May 12,
2016 
 
Three months
ended
September 30,
2015 
 
Nine months
ended
September 30,
2015 
 
Total revenue
 
$
2,354
  
$
1,423
  
$
2,974
  
Gross profit
  
2,301
   
1,247
   
2,709
  
Loss from operations
  
(13,944
)
  
(4,555
)
  
(13,899
)
 
Net loss
 
$
(13,113
)
 
$
(3,739
)
 
$
(10,708
)